This e-book identifies and describes 7 factors that are critical to the success of emerging biopharma companies as they advance their lead asset(s) through development toward approval and commercialization.
These factors are relevant to any emerging company, whether its leaders intend to out-license their lead assets, partner with other biopharma companies or organizations, or develop commercial capabilities and take assets to market.
